Noteworthy Cases

We periodically identify securities cases that we believe are appropriate for institutional leadership. These cases involve allegations of serious misrepresentations or concealed information about a company's business operations and prospects that have caused substantial losses for investors. When appropriate, we list these cases here and strongly recommend that institutional investors consider seeking to lead the prosecution of these cases. For more information about any of these cases, please send an email to BR&B partner Leslie Bornstein Molder.

Company Relevant Dates CUSIP NO.
Acadia Pharmaceuticals, Inc.
NASDAQ: ACAD
Class Period:
April 29, 2016-July 9, 2018
Lead Motion Due: September 17, 2018
004225108
Prothena Corporation, plc
NASDAQ: PRTA
Class Period:
October 15, 2015-April 20, 2018
Lead Motion Due: September 17, 2018
G72800108
Mednax, Inc.
NYSE: MD
Class Period:
February 4, 2016-July 27, 2017
Lead Motion Due: September 10, 2018
58502B106
Newel Brands, Inc.
NYSE: NWL
Class Period:
February 6, 2017-January 24, 2018
Lead Motion Due: August 20, 2018
651229106